#AUA14 - Poster: Overactive bladder patients ≥ 65 years of age have a similar efficacy and safety profile with onabotulinumtoxinA as patients less than 65 years of age

ORLANDO, FL USA (UroToday.com) - Presented by Courtenay Moore,1 Albert Kaufmann,2 Manher Joshi,3 Christopher Nardo,3 Yan Zheng,4 and Sender Herschorn5 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

aua 2014 moore age poster thumb

1Cleveland Clinic, Cleveland, OH, USA; 2Kliniken Maria Hilf GmbH, Mönchengladbach, Germany; 3Allergan, Inc., Irvine, CA, USA; 4Allergan, Inc., Bridgewater, NJ, USA; 5University of Toronto, Toronto, ON, Canada

 

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Winter Meeting / February 25-29 / Scottsdale, AZ
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Annual Congress / October 17 - October 20 / Athens, Greece
  • 2019 Annual Meeting / October 3 - October 5 / Aarhus, Denmark
  • 2019 Annual Congress / September 27 - October 1 / Barcelona, Spain
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland
  • 2019 Think Tank / August 8-10 / Washington, DC
  • 2019 Annual Meeting / May 31 - June 6 / Chicago, IL
  • 2019 Annual Meeting / May 3-6 / Chicago, IL